Target
PSMA (Prostate-Specific Membrane Antigen)
36 products, 14 indications
Indications
Metastatic Castration-Resistant Prostate Cancer (15 products)
Prostate cancer (11 products)
recurrent prostate cancer (11 products)
metastatic hormone-resistant prostate cancer (3 products)
non-metastatic castration-resistant prostate cancer (2 products)
glioblastoma (2 products)
Advanced, unresectable progressive rectal NETG1/G2 (1 products)
metastatic ocular melanoma (1 products)
recurrent prostate cancer (1 products)
Advanced or metastatic prostate cancer (1 products)
Advanced FAP-expressing solid tumors (1 products)
metastatic castration-sensitive prostate cancer (1 products)
metastatic hormone-naive prostate cancer (1 products)
refractory/relapsed cancer (1 products)
Loading...
17 drugs
Drug
SAR-bisPSMADrug
177Lu-PSMA-617Drug
CC-115Drug
actinium Ac-225Drug
J591Drug
89Zr-CB307Drug
FLOTDrug
Ac-225 PSMA-617Drug
INO-5401Drug
225Ac-J591Drug
1095Drug
TrileukinDrug
64Cu-SAR-bisPSMADrug
ATG-037